JACOBIO PHARMACEUTICALS GROUP CO., LTD. 加科思藥業集團有限公司
Pay for financial year ended 2021-12-31
Source: Annual report
Note: while most data are extracted from annual reports, some data in these tables may have been taken from supplemental filings made in response to complaints to SEHK by our volunteer editors. Please report any errors.
| Name | Last position |
Fees | Salary & benefits |
Bonus | Retire | Share- based |
Total | |
|---|---|---|---|---|---|---|---|---|
CNY '000 |
||||||||
Directors |
||||||||
| 1 | Wang, Yinxiang (1965) 王印祥 | Ch, CEO, Fdr | 2,138 | 480 | 1,862 | 4,480 | ||
| 2 | Hu, Shaojing 胡邵京 | ED | 487 | 718 | 1,205 | |||
| 3 | Wang, Xiaojie (1964) 王曉潔 | ED | 1,396 | 480 | 1,406 | 3,282 | ||
| 4 | Hu, Yunyan 胡雲雁 | ED, SVP | 1,446 | 480 | 1,061 | 2,987 | ||
| 5 | Cai, Daqing 蔡大慶 | INED | ||||||
| 6 | Song, Rui Lin 宋瑞霖 | INED | 400 | 400 | ||||
| 7 | Wu, Peter Ge 吳革 | INED | 200 | 200 | ||||
| 8 | Wu, Xiaoming (1954) 吳曉明 | INED | 200 | 200 | ||||
| 9 | Chen, Teli 陳德禮 | NED | ||||||
| 10 | Feng, Ting (1983) 馮婷 | NED | ||||||
| 11 | Lyu, Dong (1975) 呂東 | NED | ||||||
| 12 | Tang, Yanmin (1972) 唐艷旻 | NED | ||||||
| Total | 800 | 5,467 | 1,440 | 1,061 | 3,986 | 12,754 | ||
Main board pay history
Click on the year-end to see the pay details.
CNY'000
| Year-end | Fees | Salary & benefits |
Bonus | Retire | Share- based |
Total | |
|---|---|---|---|---|---|---|---|
| 2024-12-31 | 800 | 7,518 | 0 | 160 | 0 | 8,478 | Report |
| 2023-12-31 | 750 | 7,008 | 735 | 153 | 575 | 9,221 | Report |
| 2022-12-31 | 650 | 6,166 | 1,400 | 0 | 2,315 | 10,531 | Report |
| 2021-12-31 | 800 | 5,467 | 1,440 | 1,061 | 3,986 | 12,754 | Report |
| 2020-12-31 | 0 | 4,111 | 3,900 | 0 | 3,059 | 11,070 | Report |
| Total | 3,000 | 30,270 | 7,475 | 1,374 | 9,935 | 52,054 |
Want to see more years here? volunteer to be a Webb-database editor and add the data from annual reports!
Copyright & disclaimer, Privacy policy
Webb-site.com was originally created by David M Webb MBE
We are committed to maintaining high quality and expanding the database with additional data and insight.